Sessioni Comunicazioni Orali


Pharmacoeconomics, Pharmacoepidemiology & Pharmacovigilance II

Saturday, October 28th / 9.00-11.00
104Drug interactions with levothyroxine therapy: tablets versus oral liquid formulations
Lapi FL., Bianchini EB., Guglielmi VG., Cricelli CI., Bellia AB., Cricelli CC.
106Real-world evidence on the risk of acute cardiovascular events among elderly hypertensive patients treated with calcium channel blockers in secondary cardiovascular prevention
Bettiol A., Lucenteforte E., Vannacci A., Lombardi N., Onder G., Agabiti N., Vitale C., Trifirò G., Corrao G., Roberto G., Mugelli A., Chinellato A.
107ADHERENCE TO THERAPY WITH DIFFERENT SECOND-LINE HYPOGLYCAEMIC DRUGS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Galimberti F., Casula M., Mozzanica F., Scotti L., Pirillo A., Corrao G., Tragni E., Catapano AL.
108REAL WORLD DATA ON BIOLOGICAL DRUGS USED IN ONCOLOGY: A 5 YEARS PICTURE' IN SOUTHERN ITALY
Lucchesi S., Marcianò I., Randazzo M., Panagia P., Intelisano R., Sgroi C., Santarpia M., Adamo V., Franchina T., Spina E., Trifirò G.
109COMPARATIVE EFFICACY OF ANTIEPILEPTIC DRUGS IN CHILDREN AND ADOLESCENTS: A NETWORK META-ANALYSIS
Lucenteforte E., Rosati A., Ilvento L., Crescioli G., Mcgreevy KS., Pugi A., Virgili G., Mugelli A., De masi S., Guerrini R.
110Effect of Chronic Kidney Diseases on Mortality in Patients Treated with Digoxin for Non-Valvular Atrial Fibrillation: A Nationwide Register-Based Retrospective Cohort Study.
Mascolo A., Sessa M., Andersen M., Rosano G., Rossi F., Capuano A., Torp-pedersen C.
111Un-Suggested Prescriptions of Non-Cardio-Selective Beta-Blockers for Heart Failure in Patients with Concurrent Chronic Obstructive Pulmonary Disease.
Sessa M., Mascolo A., Mortensen R., Andersen M., Rosano G., Capuano A., Rossi F., Gislason G., Enghusen-poulsen H., Torp-pedersen C.
112IMMUNE RELATED ADVERSE EVENTS ASSOCIATED WITH IMMUNE CHECKPOINTS INHIBITORS: A SYSTEMATIC REVIEW AND META-ANALYSIS
Spini A., Moscatelli V., Cucherat M., Roberto G., Gini R., Raschi E., Ziche M., Salvo F.